Dr Pignone will help update the UNC-CH/RTICHD Prevention Model for use with novel cardiovascular risk markers. He will then work in collaboration with colleagues at RTI and UCSF to test, through modeling, the cost-effectiveness of using coronary artery calcium in addition to the standard Framingham risk assessment to guide cvd prevention decisions. In doing so, the team will test a variety of different clinical and policy scenarios and systematically examine the effects of key individual variables on the results. Dr. Pignone will also participate in manuscript preparation and revision.
Principal Investigator: Michael Pignone, MD
Funding: University of California at San Francisco via AHRQ
Total Project Period:07/01/2011-7/31/2013